Download Tuberous Sclerosis - Milestone Centers, Inc.

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Public health genomics wikipedia , lookup

Dysprosody wikipedia , lookup

Multiple sclerosis research wikipedia , lookup

Transcript
HCQU Northwest
Tuberous Sclerosis
April 2015, 1.5 hours
Introduction
Tuberous Sclerosis Complex (TSC), also called
Bourneville’s Disease, is a relatively rare genetic
disorder that causes benign (non-cancerous) tumors
to grow in several areas of the body. The disease
does not affect everyone the same way. Tumors vary
from person to person with regard to number, location, and severity, and the effects of the disease
range from mild to severe and debilitating. Incidence
estimates range from one out of every 6,000 to one
out of every 30,000 people world-wide. Approximately one million people have TSC; about 50,000 of them
in the USA. Treatments vary depending on what
areas of the body are affected, and a large aspect of
care involves observation and imaging in order to
monitor for changes in the size and number of tumors. The tumors in TSC are typically tough and
fibrous. There is currently no cure.
Genetics
A baby receives 23 chromosomes from each parent, resulting in a total of 46. Therefore, every cell in the
human body (except for sperm and egg cells, each of which has 23) contains 46 chromosomes. On each
chromosome there are numerous genes, varying from hundreds on some chromosomes to literally thousands
on others. The genes are like blue prints because they tell the cells what to become and how to function.
This is why people are tall or short, have green eyes or blue eyes, tend to be clumsy or athletic, and so on.
Sometimes problems occur with the genes, and a person may be born with a disease. This is the case with
Tuberous Sclerosis Complex.
Because of advanced research techniques, we have been able to identify many of these genes and discover
how they influence our health. One of the genes, known as TSC1, is found on Chromosome 9; the other is
known as TSC2 and is found on Chromosome 16. Both of these genes help to control how cells grow and
divide in the human body. You might say they are like police officers that regulate traffic and determine how
many cars are allowed to pass through an intersection. Sometimes genes develop abnormally (called
“genetic mutations”) and fail to do the job they were supposed to do. This is exactly what happens in TSC.
Mutations may develop on TSC1, on TSC2, or on both. The mutations on these genes can vary greatly in
terms of type and extent. A diagnosis of TSC is made by the presence of a combination of different major
and minor physical features of the disease. There is now also genetic testing available to determine if a
person has a mutation of TSC1 or TSC2.
If either parent has TSC, there is a 50% chance that the child will get it. This happens in about one-third of
the cases. In the other 66%, a spontaneous, unpredictable mutation may occur at conception or during the
embryonic stage. Therefore, it is virtually impossible to tell who will or will not develop the disease.
Since 1969, Milestone Centers, Inc. has provided programs and services to people with developmental and behavioral health challenges.
Tuberous Sclerosis | Page 2
HCQU Northwest
Manifestations
TSC can vary greatly in its presentation from person to
person. In some, tumors so severely impair organ
function that the disease is fatal; in others, it may be
only a cosmetic problem. Most people with the disease
fall somewhere in between. Generally, the tumors are
non-cancerous (rarely, persons can develop cancerous tumors called “Hamartoblastomas”) and can
appear at any time during one’s lifespan, although the
majority of persons who develop symptoms do so
between two and six years of age. Some have symptoms at birth and others do not develop any until
adulthood. The age at which symptoms appear does
not necessarily correlate with how severely a person is
affected.
Individuals who are mildly-to-moderately affected can
live long, healthy and productive lives. Those who
have more serious forms of TSC whose vital organs
are affected may experience complications. About
25% of severely affected infants die before age 10 and
approximately 75% die before age 25. Let us look at
the impact of TSC upon several specific organs.
The Brain
There are three types of tumors that can appear in
the brain due to TSC: Cortical Tubers (the most
common type - found in over 80% of cases with brain
involvement); Subependymal Nodules; and Subependymal Giant Astrocytomas (also known as SEGAs).
surroundings. It is important that parents notice subtle
cues and have the child examined by a neurologist
familiar with TSC because some infants can show
developmental arrest or lose milestones that were
previously achieved. The old adage, “Time lost is
brain lost,” certainly applies here, as long-term
damage may be averted. Treatment is usually with
adrenocorticotropic hormone (ACTH), or a medication
called Vigabatrin (Sabril). Vigabatrin helps to prevent
the breakdown of GABA, an important neurotransmitter in the brain. One potential side effect of Vigabatrin
that is of concern is visual field loss. Prednisone, a
corticosteroidal anti-inflammatory medication, has
also been used in treatment of Infantile Spasms.
Cortical Tubers are areas in the Cerebral Cortex
(where we do our thinking) that fail to develop normally. They often disrupt the normal wiring of the brain
and can cause seizures. It is estimated that 80% of
people with TSC experience seizures, and although
seizure onset for the majority of persons with TSC
occurs by age three, it can begin at any time during
one’s life. Usually an electroencephalogram (EEG) is
done to locate the region of the brain in which seizure
activity is occurring. Treatment is usually with anticon- Subependymal Nodules. These form beneath the
vulsant medication.
Ependymal cells, which line the ventricles of the brain
and central spinal canal, and produce cerebrospinal
Approximately one-third of infants with TSC experifluid. The nodules develop inside the walls of the
ence Infantile Spasms, seizures that cause sudden
ventricles and begin to accumulate calcium in the first
tensing of the infant’s body. Usually they occur
few months or years of life. They are not known to
somewhere between five and nine months of age,
cause any damage and can be seen with Computerand rarely before three months or after 18 months.
ized Tomography (CT scan).
Children outgrow them; either the seizures go away
altogether, or transition into other types of seizures. Subependymal Giant Astrocytomas occur in about
Infantile Spasms can produce sudden flexion 15% of persons with TSC. These typically develop in
(“jackknife seizures”), or extension, of the trunk and childhood or adolescence, and the chances of develextremities. Often, they can come in clusters, and last oping this type of tumor decrease after age 20. If a
15-20 minutes. Sometimes the seizures may be more SEGA grows large enough, it can block the flow of
subtle, such as twitching of a body part, sudden cerebrospinal fluid, causing hydrocephalus, brain
grimacing, or staring off into space, oblivious to damage, and even death. Symptoms include nausea,
HCQU Northwest
Tuberous Sclerosis | Page 3
The Brain (continued from Page 2)
vomiting, headaches, and changes in appetite,
behavior, or mood. Treatment is through surgical
resection of the tumor and/or shunting the cerebrospinal fluid in order to relieve pressure. Brain imaging
can spot this type of tumor even before symptoms
develop; scans, either CT or Magnetic Resonance
Imaging (MRI), are usually done upon diagnosis and
every 1-3 years thereafter. Ongoing monitoring, not
only for the brain but for any potentially affected
organ, is important and an essential aspect of any
treatment plan for persons diagnosed with TSC.
Brain tumors in TSC may also result in Psychiatric
and behavioral involvement. Developmental delays,
intellectual disabilities, learning disabilities, sleep
disturbances, aggression, hyperactivity, attention
deficit, OCD, Depression, Bipolar Disorder, and
Schizophrenia may also stem from the disease. In
addition, TSC provides the clearest link of any medical disorder to Autism; some 50%-60% of children
with Tuberous Sclerosis also are diagnosed with
Autism Spectrum Disorder.
Eyes
Tumors from TSC can be found in either the internal disk, and occur in 75% of people with TSC. Mulberry
or external structures of the eye. In most cases they lesions tend to grow in clusters on the optic disk.
do not interfere with vision.
Again, rarely do these tumors affect vision, but if they
Angiofibromas occur on the eyelids and usually do, an ophthalmologist can use a technique called
appear during childhood. There are also small tumors photocoagulation, which shuts off the blood supply to
that can grow on the conjunctiva (the membrane the tumors, thus eliminating them.
covering the eye).
Retinal Hamartomas are flat, translucent tumors that
grow at the back of the eye peripheral to the optic
Achromic patches are small spots which can appear
on the retina that have no color.
Skin
Skin lesions affect 75%-80% of persons with TSC. Usually they do not cause functional problems but may be
painful or disfiguring and upsetting to the patient, who may request surgical removal. These areas often
consist of light-colored, thickened skin. There are different types of skin lesions, including:

Hypo melanotic macules are patches of skin which are lighter than the surrounding skin and may appear
in a classic “ash leaf” shape.

Shagreen patches are characteristic of TSC and are considered a major feature among diagnostic criteria
for the disease. They are tough and dimpled like an orange peel.

Periungual or Subungual Fibromas are fibrous tumors that grow around or under fingernails or toenails.
These may cause pain or discomfort, particularly on the feet, where they may become compressed by
shoes, and surgical removal may be necessary to relieve the pain.

Facial Angiofibromas (formerly known as Adenoma Sebaceum) are small, reddened or yellow papules on
the face that look like acne. There may also be lesions (fibrous, hairless plaques) on the scalp and
forehead. Any or all of these may be cosmetically unsightly and distressing, in which case they can be
surgically removed.
Tuberous Sclerosis | Page 4
HCQU Northwest
Skin (continued from Page 3)

Dermatofibromas are tumors of the skin which
appear on the lower extremities. Although they
pose no functional problems, the patient may
desire removal for aesthetic purposes.

“Confetti” skin lesions are small (1-2 mm in
diameter) light-colored spots that appear on the
skin and look like confetti.
Tumors may be removed by dermabrasion (“sanding”
the lesion off), shave excision (literally slicing the
lesion away), cryotherapy (freezing), or laser surgery.
The method employed would depend on each particular case.
Lungs
There are three main types of lesions that can occur
in the lungs as a result of TSC: Lymphangioleiomyomatosis (LAM), Multifocal Micronodular Pneumocyte
Hyperplasia (MMPH), and Clear Cell Tumors. The
most dangerous of these is LAM; the other two do not
cause complications.
LAM is the development of smooth muscle tumors in
the blood and lymph vessels of the lungs and is the
most common manifestation of TSC in the lungs. LAM
occurs mostly in women of child-bearing age, with the
average onset in the early 30s. These tumors take up
space and crowd out functional lung tissues. They
can also rupture and cause a collapsed lung. LAM
progressive and eventually destroys the function of
the lungs, resulting in respiratory failure and death
over a period of several years.
of respiratory distress, he or she should be sent to the
emergency room.
Females with TSC should have a CT scan (a chest xray would not detect early signs of involvement)
before the age of 18 or at the time of diagnosis for
both women and men if it is past the age of 18. The
patient should be monitored closely and should have
follow-up CT scans as needed. CT scans allow
physicians to view masses and track tumor proliferation.
Many people with TSC have minor, asymptomatic
lung involvement. Those with more severe symptoms
should see a pulmonologist who is knowledgeable
regarding LAM. It is always better to be pro-active
than to wait until a crisis develops in order to treat any
health problem. LAM is a major feature of the diagShortness of breath, especially after exercise, is nostic criteria of TSC and sometimes provides the
usually the first symptom when LAM begins forming in very first indication that someone has the disorder.
the lungs. A spontaneous pneumothorax (collapsed
Treatment for LAM depends on symptoms. Commonlung) results when a cyst ruptures, creating a small
sense approaches include exercising to tolerance,
hole in the lining of the lung. The rupture allows the quitting/avoiding smoking, and receiving flu and
surrounding air to escape into the chest cavity, pneumonia vaccines. Beta agonist inhalers (such as
causing the lung to collapse. The result is dyspnea Albuterol) which relax the smooth muscles of the
(difficulty breathing), chest pain, coughing, and airways, can help relieve shortness of breath, as can
fatigue. This requires immediate medical attention. supplemental oxygen. Medications such as TamoxiRespiratory failure can result. Treatment is insertion fen and Progesterone have been used also, but their
of a chest tube, which allows the air to escape from effectiveness has been questionable. Rapamycin
the chest cavity and the lung to re-inflate. In some (Sirolimus) is an immunosuppressive medication that
cases a collapsed lung may resolve on its own, can slow the progression of LAM, but it has side
however, any time a person presents with symptoms effects, including increasing the risk of cancer or
HCQU Northwest
Tuberous Sclerosis | Page 5
Lungs (continued from Page 4)
infection. Thoracentesis is a method of draining fluid
from the lungs to relieve congestion. Finally, a lung
transplant can be performed, but this is major sur-
gery, and complications may include rejection of the
donor organ, infection, bleeding, pneumothorax, and
recurrence of LAM.
Heart
Cardiac Rhabdomyomas appear in 47% to 67% of
persons with TSC and are considered a major
feature in diagnosing TSC. “Rhabdo” means “rodlike” and “myoma” means “muscle tumor.” The
tumors grow during pregnancy and are largest at
birth or shortly thereafter and then regress; some
disappear entirely. Occasionally there may be a
second peaking of tumor growth at puberty. Of all
the tumors caused by Tuberous Sclerosis Complex,
these are the only ones that decrease in size with the
passage of time.
Most Rhabdomyomas are asymptomatic, but if an
arrhythmia (irregular heartbeat) or some other
cardiac abnormality is present, the infant should be
seen by a cardiologist immediately. A child with TSC
who takes Tegretol for Infantile Spasms (seizures)
may develop an arrhythmia. Infants taking adreno-
corticotropic hormone (ACTH) for the same have
shown an increase in the size of Rhabdomyomas. An
echocardiogram is a motion picture of the heart
which allows the physician to see it operating through
time and notice any tumors. An electrocardiogram
measures the electrical activity of the heart. Both of
these tests should be done for any infants who are
suspected of having Rhabdomyomas, and especially
before they begin taking the aforementioned medications.
Rhabdomyomas are considered a major diagnostic
feature of TSC. When tumors are large or grow on
or near heart valves, they can obstruct blood flow
and lead to heart failure. This occurs in only 2%-4%
of children with Rhabdomyomas. Surgical resection
of these tumors is reserved for severe cases.
Kidneys
There are several types of tumors which invade the
kidneys due to TSC: Benign Angiomyolipomas,
Malignant Angiomyolipomas, Renal Cell Carcinoma,
Oncocytomas, and Cysts. Remember that the kidneys are highly vascular organs; their principal job is
to filter waste products from the bloodstream. Therefore, along with the brain, heart and lungs, tumor
invasion can have devastating consequences.
imaged at the time of diagnosis and regularly
throughout their lives. When these tumors grow to be
larger than 4 cm in diameter, they usually cause
bleeding in the urine (hematuria), and pain in the low
back, abdomen, flank, or pelvis can become a
significant problem. It should be noted that a person
without TSC can also develop Angiomyolipomas.
People with Benign Angiomyolipomas who also have
TSC have a greater risk of developing Malignant
Angiomyolipomas are fatty tumors (lipomas) that form
Angiomyolipomas than people with Benign Angiomyin the smooth muscles (myo) of the blood vessels
olipomas who do not have TSC.
(angio). The most common TSC lesions are the
Benign Angiomyolipomas, occurring in 70%-80% of Malignant Angiomyolipomas are life-threatening. It is
adults. These can remain asymptomatic for a long very important that the physician consult with a skilled
time. The tumors tend to begin in childhood, grow radiologist when reviewing imaging studies in order to
very slowly, and do not usually become a problem differentiate between benign and malignant tumors.
until young adulthood. They are multiple and bilateral. Malignant Angiomyolipomas should be surgically
Individuals with TSC should have their kidneys removed as soon as possible.
Tuberous Sclerosis | Page 6
HCQU Northwest
Kidneys (continued from Page 5)
Renal (meaning kidney) Cell Carcinomas are rare in
people with TSC, but when they occur, they are often
bilateral. A biopsy is necessary to give a definitive
diagnosis, and the tumor should be surgically removed a.s.a.p. As with Malignant Angiomyolipomas,
Renal Cell Carcinoma is more likely to occur in people
who have TSC than in people who do not. It should
be noted that biopsies are discouraged for cancerous
tumors of kidneys because of the high risk of hemorrhaging and spreading the tumor cells.
Oncocytomas are brown-colored tumors of the kidney
which can cause flank pain and bleeding in the urine.
These can be detected with a CT scan or ultrasound,
but cannot be differentiated from Renal Cell Carcinoma without a biopsy. Removing the section of the
kidney containing the tumors (partial nephrectomy) is
recommended.
Renal Cysts associated with Tuberous Sclerosis are
usually multiple and bilateral. After Benign Angiomyolipomas, they are the most commonly occurring
kidney manifestation of TSC. Some of them collapse
and disappear over time. They are similar to those in
Polycystic Kidney Disease (PKD). Interestingly, the
TSC2 gene affected in Tuberous Sclerosis is in close
proximity to the Polycystic Kidney Disease gene,
PKD1, located on chromosome 16.
Although kidney problems secondary to TSC can
manifest anytime in life, they usually do not present
until after age five or in young adulthood. When the
disease is diagnosed, imaging of the kidneys is
performed and subsequently routinely scheduled.
Ultrasound is usually adequate to identify tumors, but
sometimes a physician will want a higher-resolution
image in order to differentiate as to whether a tumor is
benign or malignant, so a CT scan or MRI (with or
without contrast dye) may be ordered. Physicians are
reluctant to perform biopsies on Angiomyolipomas
because the kidneys are so highly vascular that
perforating the tissues may spread potentially cancerous cells into the bloodstream. Blood tests may also
be ordered to monitor kidney function. Obviously if
symptoms (flank pain, blood in urine) develop, the
physician should be notified.
In many cases kidney tumors caused by TSC do not
present problems for the patient and careful monitoring is sufficient. There are, however, instances in
which more needs to be done. Sometimes tumors on
or in the kidneys can interfere with their ability to filter
waste from the blood. A bi-product of protein digestion
is ammonia, which converts to uric acid in the kidneys
and then is excreted. When this function is compromised, the patient may need to go on a low-protein
diet in order to reduce the ammonia build-up and
therefore the workload on the kidneys.
Another important aspect of kidney function is regulating blood pressure, and in some people, renal cysts
or tumors contribute to hypertension, and it may be
necessary for the physician to prescribe blood pressure medication.
There is a procedure which allows a physician to stop
the blood supply to certain tumors in the kidneys
called Selective Embolization. A catheter is inserted
through the renal artery into the particular blood
vessel that feeds the tumor and shuts off the blood
flow, resulting in the subsequent death of the tumor.
In cases where this procedure fails or is not possible,
surgery is performed to remove part or all of the
kidney. This is called a partial or total nephrectomy.
Kidneys can be damaged so badly by TSC-related
tumors that they begin to fail, in which case Hemodialysis may be necessary. This is a procedure which
uses a dialysis machine to artificially cleanse a
person’s blood. It is time-consuming and usually
tiresome for the patient. Dialysis is typically performed
three times per week at a clinic.
The final available option is a kidney transplant, which
has been done successfully in persons with TSC, and
there does not seem to be a recurrence of tumors in
the transplanted organ. Remember that early detection and frequent monitoring of renal tumors allow
physicians to recognize potential problems sooner,
and thus be able to use less invasive methods like
embolization instead of more drastic surgical procedures like nephrectomies and transplants.
HCQU Northwest
Tuberous Sclerosis | Page 7
Other Sites
Tuberous Sclerosis Complex may
cause growths in other parts of the
body, where they usually do not
appear until later in life and rarely
cause problems.
tooth decay. Even though cysts on
gums and pits in teeth are considered minor diagnostic features,
they are good indicators that a
person has TSC.
Seventy percent of people with
TSC develop nodular growths on
their gums (intraoral fibromas), and
nearly 100% develop dental pits in
the enamel of their teeth. Dentists
recommend coating the teeth and
good dental hygiene to prevent
Angiomyolipomas occur in the liver
about 25% of the time in people
who have Tuberous Sclerosis,
more often in women than in men.
Usually they pose no problems,
but in rare cases they require
surgical removal.
Pancreatic tumors are generally
asymptomatic, but can cause
hypoglycemia, behavioral changes, and abdominal pain.
The spleen is generally unaffected
by TSC, but there have been
instances of progressive lesions
called Hemangiomatous Malformations that required a splenectomy.
Diagnosing TSC
A diagnosis of Tuberous Sclerosis can be made the head or at least three Angiofibromas on the face
based on clinical features of the disease or by genetic (these look like acne); and the presence of at least
testing.
three Hypomelanic Macules (white spots), greater
than 5 mm in diameter.
With regard to clinical features, a definitive diagnosis
requires at least two major features or a combination Minor features: Confetti lesions, dental enamel pits,
of one major feature and at least two minor features. intraoral fibromas of the gums, achromic patches in
For a possible diagnosis, there must be one major the eye, multiple renal cysts, and finally, the presence
feature or at least two minor features.
of benign tumors which are not considered major
features (as listed above) growing anywhere else in
The major features include: Rhabdomyoma of the
the body.
heart; Lymphangioleiomyomatosis (LAM) of the lungs;
at least two Angiomyolipomas present in one or both Advancements in medical science now allow for
kidneys; presence of any one of the three types of genetic testing to determine if someone has TSC. A
brain tumors (Cortical Tubers, Subependymal Nod- sample of cells from the patient is taken and examules, Subependymal Giant Astrocytoma); multiple ined in the laboratory. The identification of a mutation
Retinal Hamartomas of the eye; a Shagreen Patch on of the TSC1 or the TSC2 gene is sufficient to confirm
the skin; at least two Ungual Fibromas (either on the diagnosis of Tuberous Sclerosis Complex.
fingernails or toenails); presence of Fibrous Plaque on
Tuberous Sclerosis | Page 8
HCQU Northwest
Care of the Patient
Caring for someone with TSC involves a great deal of
monitoring. Recall that heart tumors present the
greatest danger to infants and tend to abate with time
(except for a possible flare-up during the teens), and
tumors in other areas of the body usually begin later
in life and worsen over time. Since the most frequently involved organs include the brain, heart, lungs,
kidneys, eyes and skin, periodic examinations by a
physician and/or the use of imaging are standard
procedure. Some people are only mildly affected by
TSC and others may be facing life-threatening situations, so treatments will vary greatly. Symptoms in the
same person may change over time as well. Often the
health care team will involve not only the PCP but
also one or more specialists, so there must be collaboration among physicians, since organs and organ
systems directly affect one another.
What is essential is that the individual be diagnosed
early and monitored frequently so that intervention
may be timely. This is why CT scans and MRIs are
ordered routinely for the brain, lungs and kidneys at
least as often as every one to three years. Catching a
problem early increases the chances for effective
treatment. Family members and caregivers must also
be observant and note any new signs or symptoms,
so that the physician can be notified. Sticking with the
plan of care involves observing, reporting, communicating with the physician, implementing care, noticing
what is working and what is not, and documenting
significant observations. Especially with individuals
who have intellectual or developmental disabilities, it
is important that direct supports keep physicians
informed and updated in the event that the individual
cannot.
Genetic Testing and Genetic Counseling
Advancements
in
technology
enable us to look at the genetic
material (DNA) of any person.
DNA is more or less a blueprint for
the structure and function of our
own unique physical body. All that
is necessary is to obtain a sample
of cells, which can then be tested
in a laboratory.
reveal it, and thus can help families assess the possible outcomes
of decisions they make for the
future. It is also important to realize
that mildly affected parents do not
always have mildly affected
children; the children may, in fact,
be severely affected, as the
disease is quite unpredictable in
how it manifests from one person
All immediate family members of
to the next.
someone with TSC should undergo genetic testing, as the results A genetic counselor can explain
may help identify where the how mutations occur and how they
mutation arose and who may be are passed on, as well as help
affected. Remember that a genetic people with TSC construct a family
mutation can occur spontaneously medical history to determine where
and without the involvement of the TSC1 or TSC2 mutation (if
heredity, but if there is a familial there is one) occurred. Medical
component, genetic tests can science has not found a way to
prevent an existing mutation from
being passed on, so there are no
guarantees that the children of a
parent with TSC will not inherit it.
Finally, for expectant parents,
there are ways to test for genetic
mutations in the child before it is
born. The first is through amniocentesis, a procedure that uses a
needle to withdraw amniotic fluid
from within the mother’s uterus.
The second is through chorionic
villi sampling, which involves
removing a piece of the placenta
during pregnancy. A third method,
reserved for in-vitro fertilization, is
to sample a cell from an embryo
prior to implantation in the womb.
MilestonePA.org
HCQU Northwest
Tuberous Sclerosis Test
Name: ___________________________
Role/Title: _________________________
Agency: __________________________
Date: ______________________
Please provide contact information (email address, fax number, or mailing address) where you would like
your certificate to be sent:
_______________________________________________________________________________________
Submit your completed test, with at least a score of 80%, to receive 1.5 hours of credit for this course.

To submit via fax, please fax the test and evaluation to 814-728-8887. Please fax only the test and evaluation, not the entire training packet.

To submit via email, please send an email to [email protected]. Please put “Tuberous Sclerosis
Test” in the subject line, and the numbers 1—10 along with your answers, in the body of the email, OR
scan the test and evaluations pages and email as attachments.

To submit via mail, send the test and evaluation pages to Milestone HCQU NW, 247 Hospital Drive,
Warren PA 16365.
Knowledge Assessment:
1. Tuberous Sclerosis is an exclusively inherited disease. True
False
2. Most frequently, tumors caused by TSC occur in the bladder and small intestine. True
False
3. Tuberous Sclerosis can be diagnosed definitively if someone carries two major features, or one major feature and at least two minor features. All of the following are major features except
a. Any of the three types of brain tumors
b. Angioleiomyomatosis (LAM) of the lungs
c. Achromic patches on the retina of the eye
d. Angiomyolipomas of the kidneys
4. Rhabdomyomas of the heart
a. Are largest at or near birth and tend to shrink over time
b. Only necessitate surgery in 2%-4% of cases
c. If suspected, warrant an echocardiogram and an EKG
d. All of the above
e. None of the above
5. Lymphangiomyomatosis (LAM) of the lungs occur mostly in women. True
False
6. Angiomyolipomas of the kidneys can become cancerous. True
False
7. ___________________ tubers tend to cause seizures in people with TSC?
8. Skin lesions caused by Tuberous Sclerosis rarely affect function, except to cause pain near fingernails and
toenails. True
False
9. Genetic testing can identify immediate family members who have genetic mutations. True
False
10. The most important aspect of caring for any person who has TSC is
a. Frequent monitoring
b. Genetic Testing
c. Medications
d. Surgery
MilestonePA.org
HCQU Northwest
Home Study Evaluation
Training Title: Tuberous Sclerosis
Date:
□ Direct Support Professional □ Provider Administrator/Supervisor
□ Program Specialist
□ Provider Clinical Staff
□ Consumer/Self-Advocate
□ Family Member
□ Support Coordinator
□ Support Coordinator
Supervisor
□ PCH Staff/Administrator
□ County MH/MR/IDD
□ FLP/LSP
□ Other (please list):
Please circle your PRIMARY reason for completing this home-study training:
 It’s mandatory
 interested in subject matter  need training hours
 convenience
Please circle the best response to each question.
5 = Strongly Agree 4 = Agree
3 = Undecided
2 = Disagree 1 = Strongly
1.
As a result of this training, I have increased my knowledge.
5
4
3
2
1
2.
I learned something I can use in my own situation.
5
4
3
2
1
3.
This training provided needed information.
5
4
3
2
1
4.
The training material was helpful and effective.
5
4
3
2
1
5.
Overall, I am satisfied with this training.
5
4
3
2
1
6.
I am glad I completed this training.
5
4
3
2
1
Suggestions for improvement:
Additional information I feel should have been included in this training:
I would like to see these topics/conditions developed into home-study trainings: